Jaktinib
Jaktinib is a pharmaceutical drug with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
3
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)
Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis
A Study to Evaluate the Effect of Jaktinib on QT/QTc Interval in Healthy Participants
Clinical Trials (10)
Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)
Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis
A Study to Evaluate the Effect of Jaktinib on QT/QTc Interval in Healthy Participants
Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS)
Jaktinib Versus Hydroxycarbamide in Subjects With Intermediate-2 or High-risk Myelofibrosis
Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis
Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumonia.
Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10